Your browser doesn't support javascript.
loading
Metastatic or locally advanced breast cancer patients: towards an expert consensus on nab-paclitaxel treatment in HER2-negative tumours-the MACBETH project.
Cazzaniga, Marina E; Ciruelos, E; Fabi, A; Garcia-Saenz, J; Lindman, H; Mavroudis, D; Schem, C; Steger, G; Timotheadou, E; Zaman, K; Torri, V.
Affiliation
  • Cazzaniga ME; Phase 1 Trials Research Unit and Oncology Unit, ASST Monza and Milano Bicocca School of Medicine, Via GB Pergolesi 33, 20900, Monza, MB, Italy. marina.cazzaniga@asst-monza.it.
  • Ciruelos E; Oncology Unit, ASST Monza, Monza, Italy. marina.cazzaniga@asst-monza.it.
  • Fabi A; Unidad de Cáncer de Mama del Centro Integral Oncológico Clara Campal HM CIOCC, Madrid, Spain.
  • Garcia-Saenz J; Medical Oncology, Regina Elena National Cancer Institute, Rome, Italy.
  • Lindman H; Department of Medical Oncology, IdISSC. CIBERONC-ISCIII, Hospital Clínico San Carlos, Madrid, Spain.
  • Mavroudis D; Department of Immunology, Genetics and Pathology, University of Uppsala, Uppsala, Sweden.
  • Schem C; Department of Medical Oncology, University Hospital of Heraklion, Heraklion, Crete, Greece.
  • Steger G; Mammazentrum, Hamburg, Germany.
  • Timotheadou E; Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.
  • Zaman K; Aristotle University of Thessaloniki School of Medicine, Papageorgiou Gen. Hospital, Thessaloníki, Greece.
  • Torri V; Breast Center, Department of Oncology, University Hospital CHUV, Lausanne, Switzerland.
Cancer Chemother Pharmacol ; 83(2): 301-318, 2019 02.
Article in En | MEDLINE | ID: mdl-30460489

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Paclitaxel / Practice Guidelines as Topic / Receptor, ErbB-2 / Albumins Type of study: Guideline / Prognostic_studies Limits: Female / Humans Language: En Journal: Cancer Chemother Pharmacol Year: 2019 Type: Article Affiliation country: Italy

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Paclitaxel / Practice Guidelines as Topic / Receptor, ErbB-2 / Albumins Type of study: Guideline / Prognostic_studies Limits: Female / Humans Language: En Journal: Cancer Chemother Pharmacol Year: 2019 Type: Article Affiliation country: Italy